Work

How to improve treatment persistence among patients with fibrosing interstitial lung disease on nintedanib without sacrificing effectiveness: A possible answer from Japan

Year: 2026

Type: article

Source: Annals of the American Thoracic Society

DOI: 10.1093/annalsats/aaoag133

Authors: Francesco Bonella, Sebastian Majewski

Institutions: Ruhrlandklinik, University of Duisburg-Essen, Medical University of Lodz

Language: English

Topic: Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7203621992

FWCI:

Cites: 10

Cited by:

Related to: